Vanda Pharmaceuticals Initiated at Outperform by Oppenheimer
Ratings actions from Benzinga: GMT) Vanda Pharmaceuticals Price Target Announced at $10.00/Share by OppenheimerRatings actions from Benzinga
Related stories
Russian defence ministry: struck Ukrainian energy and transport infrastructure used by military, drone production and storage facilities
L impact | NEWS | Nov 14, 2026, 09:06 AM UTC
Zelenskiy: US envoys said Putin agreed to include Europe at next negotiation round
L impact | NEWS | Nov 14, 2026, 09:03 AM UTC
Zelenskiy: asked European allies to decide by end of November who will represent Europe in peace talks
L impact | NEWS | Nov 14, 2026, 09:03 AM UTC
UK Civil Aviation Authority: US flights resume after FAA lifts ground stop, but follow-on disruption expected as airlines rebook passengers
L impact | NEWS | Nov 14, 2026, 08:30 AM UTC
Microsoft on outage: completed work to resolve root issue, restored service to affected customers and regions
L impact | NEWS | Nov 14, 2026, 06:37 AM UTC
Microsoft on outage: services across previously impacted environments have been restored
L impact | NEWS | Nov 14, 2026, 03:59 AM UTC